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Abstract 
Background: Dysphagia is associated with aspiration pneumonia after stroke. Data are limited 
on the influences of dysphagia screen and assessment in clinical practice. 
Aims: To determine associations between a ‘brief’ screen and ‘detailed’ assessment of 
dysphagia on clinical outcomes in acute stroke patients. 
Methods: A prospective cohort study analysed retrospectively using data from a multi-centre, 
cluster cross-over, randomised controlled trial (Head Positioning in Acute Stroke Trial 
[HeadPoST]) from 114 hospitals in nine countries. HeadPoST included 11,093 acute stroke 
patients randomised to lying-flat or sitting-up head positioning. Herein, we report pre-defined 
secondary analyses of the association of dysphagia screening and assessment, and clinical 
outcomes  of pneumonia and death or disability (modified Rankin scale 3-6) at 90 days. 
Results: Overall, 8784 (79.2%) and 3917 (35.3%) patients were screened and assessed for 
dysphagia, respectively, but the frequency and timing for each varied widely across regions.  
Neither use of a screen nor an assessment for dysphagia were associated with the outcomes, but 
their results were: compared to ‘screen-pass’ patients, those who failed had higher risks of 
pneumonia (adjusted odds ratio[aOR] 3.00, 95% confidence interval[CI] 2.18-4.10) and death 
or disability (aOR 1.66, 95%CI 1.41-1.95).  Similar results were evidence for the results of an 
assessment for dysphagia. Subsequent feeding restrictions were related to higher risk of 
pneumonia in patients failed dysphagia screen or assessment (aOR 4.06, 95%CI 1.72-9.54). 
Conclusions: Failing a dysphagia screen is associated with increased risks of pneumonia and 
poor clinical outcome after acute stroke. Further studies concentrate on determining the 
effective subsequent feeding actions are needed to improve patient outcomes.   
Introduction 
Pneumonia is a common complication of acute stroke, which increases the likelihood of death 
and poor recovery, and costs of care.1-3  As dysphagia is also common and associated with 
aspiration pneumonia,4,5,6 stroke management guidelines recommend that health professionals 
screen for this impairment before their patients receive any oral intake of food, fluid or 
medications.7-12  However, the evidence base supporting this recommendation is of moderate 
grade, with only one cluster clinical trial of implementing protocols that included dysphagia 
screening/assessment in conjunction with fever and hyperglycaemia management showing 
improved short and long-term clinical outcomes.13  A small ‘before-and-after’ study showed 
that the implementation of dysphagia screening by nurses reduced pneumonia and length of 
stay in hospital,14 while delays in screening and assessment for dysphagia in patients were 
associated with pneumonia in the UK national stroke registry.15  Although a range of simple 
and systematic approaches exist for the assessment of dysphagia, data are limited on how well 
these are incorporated into clinical pathways and influence feeding actions and clinical 
outcomes in practice.14  The international Head Positioning in Acute Stroke Trial (HeadPoST) 
dataset,16 therefore, provides an opportunity to examine the utility of screening and assessment 
of dysphagia, and feeding actions, on key clinical outcomes in a large cohort of stroke patients 
with a broad range of characteristics who were recruited from 114 hospitals in nine countries. 
Methods 
Design 
This study is a pre-defined secondary analysis of HeadPoST, the design and main results of 
which are outlined in detail elsewhere.16  In brief, HeadPoST was an international, multicentre, 
cluster cross-over, randomised controlled trial of two different head positions in 11,093 adult 
patients with acute stroke undertaken between March 2015 and November 2016.  Patients were 
excluded if they had resolved neurological symptoms consistent with a transient ischaemic 
attack, a clear contraindication to either head position, any medical condition that would 
compromise adherence to the protocol or assigned head position, or refusal to participate.  The 
main results showed there were no significant differences in disability outcomes and risks 
between those assigned to the lying-flat or sitting-up head positions for at least 24 hours after 
hospital admission.  The study was approved by ethics committees of participating sites.  
Consent was obtained from all patients or appropriate surrogates for participation, use of 
medical data, and central follow-up assessment. 
Assessments 
After central randomisation, stratified by country, centres were required to implement the first 
assigned intervention position until a target number of consecutive patients was reached, before 
crossing over to apply the other intervention to a similar number of consecutive patients.  Data 
collection included the time, result and action of any: dysphagia screen, defined as use of a 
simple brief non-invasive bedside test, such as a drinking a sip of water; and any dysphagia 
assessment, defined as a more systematic examination performed by a speech 
pathologist/therapist or qualified clinician, according to local standard protocols.  Only data 
pertaining to the first performed dysphagia screen/assessment were recorded.  In practice, 
patients should have a dysphagia assessment after failing a dysphagia screen,12 and the results 
used to inform a local treatment plan to prevent aspiration pneumonia.  As this was a pragmatic 
study, the specific practitioner, tool and approach to any dysphagia screen/assessment, were not 
specified in the protocol. Moreover, the study protocol allowed some flexibility in the assigned 
head position: to address any potential investigator concerns over harms, those patients 
allocated to the lying-flat position could be turned to their side; and patients assigned to either 
head position could have this interrupted for short intervals (≤3 non-consecutive periods for 
<30 min) for feeding or mobility over the required 24 hours of applying the intervention, if it 
was considered necessary.  
Outcome 
The primary outcome for these analyses was pneumonia, reported as a serious adverse event, 
and classified according to the following pre-defined criteria:17 ‘definite’ pneumonia included 
≥3 features of new or worsening cough, increased respiratory rate, oxygen desaturation, 
fever >38° Celsius, leukocytosis or leukopenia, and purulent secretions, rales or bronchial 
breath sounds over the chest together with positive radiological abnormalities (patchy 
infiltration, lobar consolidation or pleural effusion); ‘probable’ pneumonia was defined as ≥3 
of the listed features but without any radiological abnormalities, and; ‘uncertain’ pneumonia 
was <3 features with or without an abnormal X-ray.  The secondary outcome was death or 
disability, defined as scores 3-6 on the modified Rankin scale (mRS) on blinded assessment at 
90 days post-randomisation.  
Statistical analysis 
Both individual and hospital baseline characteristics were assessed in univariate analyses.  
Predictors of dysphagia screening (or assessment) and the outcomes of interest were determined 
by Chi-square test for categorical variables, t-test for approximately normally distributed 
variables, and Wilcoxon rank-sum test for skewed continuous variables.  Variables identified 
with p values <0.2 were included in multivariable models.  All potentially significant predictors 
were included in multilevel logistic regression models to estimate associations (Supplemental 
Table S1-S2). The primary analyses were the associations between use of a dysphagia screen 
(as a quality of stroke care performance measure, yes vs. no) and its result (fail vs. pass) on the 
outcomes of pneumonia and death or disability (mRS 3-6), independent of having a dysphagia 
assessment. Secondary analyses were for associations of a dysphagia assessment according to 
dysphagia screen status (unscreened, pass, and fail) and clinical outcomes.  A complete case 
dataset was used to build models for analysing each of the association.  The term ‘unadjusted’ 
was used in an initial, binomial logistic regression, hierarchical mixed model, where adjustment 
was made for the study design with fixed effects of head position (lying-flat vs. sitting-up) and 
crossover period, and random effects of cluster and interaction between cluster and crossover 
period.  Sequential multi-level models were then ‘adjusted’, first for region of recruitment, and 
then with the addition of pre-specified baseline covariates and hospital characteristics.  A further 
analysis was conducted to explore the influence of feeding restrictions on clinical outcomes in 
patients who either failed screening or assessment.  Any interactions between significant 
variables and dysphagia screen/assessment were checked in each level of the models, and only 
those that were significant (P<0.01) were included in the final model.  Associations between 
exposures and outcomes were assessed across the pre-defined subgroups of the main trial.  
Multiple imputation was used for sensitivity analysis due to 12% missing data on 90-day 
clinical outcome.  Ten imputed datasets were generated and the odds ratio were pooled from 
the imputation analysis. Data are reported with odds ratios (OR) and 95% confidence intervals 
(CI), and a standard level of significance was used (P<0.05).  No adjustments were made for 
multiplicity or missing data.  All analyses were performed with SAS Software version 9.3 (SAS 
Institute, Cary, NC). 
Results 
Frequency and time of dysphagia screen and assessment 
Among 11093 HeadPoST participants, there were 15 patients without any details on the use of 
dysphagia screening nor assessment.  Overall, there were 8784 (79.2%) and 3917 (35.3%) 
patients who had a screen and assessment for dysphagia, respectively, but the frequency and 
timing for each varied significantly across regions (Table 1). Frequency of dysphagia screening 
was low in China (69.2%) and South America (61.5%) compared to Australia/UK (91.4%) and 
India/Sri Lanka (87.0%).  Conversely, the frequency of dysphagia assessment was highest in 
South America (62.3%) compared to the other regions (range, 23.3% to 35.5%).  Overall, 
median times from admission to dysphagia screen and assessment were 2.2 hours (IQR 0.8-6.3) 
and 12.5 hours (IQR 1.8-28.0), respectively, but this varied from approximately 1 to 38 hours 
across regions, being shortest in China and longest in South America (Table 1). The majority of 
dysphagia assessments were undertaken subsequent to dysphagia screening; only 3% had an 
assessment recorded before a dysphagia screen. 
Table 1. Frequency and timing of dysphagia screening and assessment in 11,093 stroke 
patients, by region of recruitment 
 
Dysphagia screen performed  
  Dysphagia assessment 
performed 
 
 
 
Region N  
(%) P valuea 
Time from 
hospital arrival 
Median (IQR), 
hrs 
 
 
P valueb 
  
 
N  
(%) 
 
 
P valuea 
Time from 
hospital arrival 
Median (IQR), 
hrs 
 
 
P valueb 
Overall 
(N=11,093) 8784 (79.2) 
 2.2 (0.8-6.3)   3917 
(35.3) 
 12.5 (1.8-28.0)  
Region          
  Australia/UK 
(N=4761) 4338 (91.4) 
<0.0001 2.6 (1.1-5.7) <0.0001  1684 
(35.5) 
<0.0001 20.0 (6.2-34.1) <0.0001 
  Chinac 
(N=4652) 3218 (69.2) 
 1.2 (0.5-3.4)   1488 
(32.0) 
 1.4 (0.7-4.4)  
  India/Sri Lanka 
(N=770) 670 (87.0) 
 6.5 (1.5-19.0)   179 
(23.3) 
 19.0 (6.8-48.0)  
  South America 
(N=910) 558 (61.5) 
 26.7 (12.8-46.6)   566 
(62.3) 
 37.5 (20.9-54.2)  
aP value obtained from Chi-square test. 
bP value obtained from Mann Whitney Test (Wilcoxon rank sum test). 
cincludes Taiwan. 
 
Baseline and hospital characteristics by screening and assessment 
Patients without a dysphagia screen were younger, had greater pre-morbid disability, and more 
severe neurological impairment at the time of presentation (Supplemental Table S3). At hospital 
level, patients from hospitals with a stroke unit, guidelines for acute stroke treatment, local 
special pathways from stroke care, local protocols for swallow dysfunction, and speech 
pathologists, were more likely to receive screening (Supplemental Table S4).  In comparison, 
in hospital with available protocol for swallow dysfunction, neurologists, dysphagia specialist 
nurses and speech pathologists, patients were more likely to have further dysphagia assessment 
(Supplemental Table S5).  
Results of dysphagia screen and further assessment 
Overall, 22.8% (2004/8784) of patients failed a dysphagia screen (Table 2; Supplementary 
Figure S1).  Compared to those who passed, dysphagia screen-fail patients were significantly 
older, with greater pre-morbid disability, cardiovascular disease and chronic obstructive 
pulmonary disease, and more severe baseline neurological impairment (Table 2).  Of the 6778 
patients who passed the dysphagia screen, 1775 (26.2%) proceeded to a dysphagia assessment, 
which was passed by the great majority (96.1%).  There were 2292 patients who did not have a 
dysphagia screen, of whom 739 (32.2%) proceeded to a dysphagia assessment (Supplemental 
Figure S1).  They were older, more often female, with greater pre-morbid dependency and more 
severe baseline neurological impairment without coma, and more often placed on a feeding 
restriction regime, compared to those without a dysphagia assessment (Supplemental Table S6).  
Of the 2003 dysphagia screen-fail patients, there were 1402 (70.0%) who proceeded to a 
dysphagia assessment; they tended to have milder neurological impairment compared to the 
601 patient who did not have a dysphagia assessment (Supplemental Table S7).  Patients who 
neither had a screen nor assessment were younger, had lower NIHSS scores, were less 
dependent and free of prior medical history, but with higher GCS scores at baseline 
(Supplemental Table S8). 
 
Table 2.  Baseline characteristics of patients, by result of dysphagia screen 
 
Baseline characteristics 
Pass  
N=6778 
Fail 
N=2004   
 
P Value 
Age, years 66.9±13.6 72.5±14.1 <0.0001 
Male  4215 (62.2) 1062 (53.0) <0.0001 
Pathological subtype    
  Acute ischaemic stroke  5749 (85.0) 1715 (86.0) <0.0001 
  Intracerebral haemorrhage 492 (7.3) 211 (10.6)  
  Uncertain  523 (7.7) 69 (3.5)  
GCS score 15 (15-15) 14 (11-15) <0.0001 
  Severe (3-8) 67 (1.0) 117 (5.8) <0.0001 
NIHSS score 4 (2-6) 11 (6-18) <0.0001 
  Severe ≥15 258 (3.8) 705 (35.2) <0.0001 
Pre-stroke mRS score   <0.0001 
  Independent (0-1) 5504 (81.2) 1474 (73.6)  
  Mild disability but independent (2) 676 (10.0) 206 (10.3)  
  Disabled (3-5) 590 (8.7) 317 (15.8)  
Prior cardiovascular diseasea  3373 (49.8) 1137 (56.7) <0.0001 
Prior COPD 238 (3.5) 91 (4.6) 0.030 
Time to screen, hrs 2.0 (0.8-5.8) 2.7 (1.0-10.5) <0.0001 
  >24 hrs 405 (6.5) 262 (14.0) <0.0001 
Feeding restrictions 750 (11.2) 1681 (84.1) <0.0001 
Data are n (%), mean±SD, or median (interquartile range). 
GCS denotes Glasgow coma scale, NIHSS National Institute of Health Stroke Scale, COPD 
chronic obstructive pulmonary disease. 
aincludes history of heart disease, stroke or diabetes mellitus
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Pneumonia outcome 
Overall, 362 (3.3%) patients developed pneumonia, but the frequency varied significantly 
across regions and according to the use, and results of, a dysphagia screening and assessment 
(Supplemental Table S9).  In particular, the frequency of pneumonia was higher in those who 
had dysphagia screen (or assessment), and especially in those who failed, and it was also 
associated with longer times to having a dysphagia screen (and assessment) (Supplemental 
Tables S9 and S10). 
In multivariable analysis adjusted both individual and hospital level of characteristics, there 
was no association between the use of dysphagia screen and pneumonia (adjusted odds ratio 
[aOR] 1.20, 95% CI 0.82-1.75; Figure 1A).  However, compared to those who passed a 
dysphagia screen, screen-fail patients had a significantly higher risk of pneumonia (1.5% vs. 
10.0%; aOR 3.00, 95%CI 2.19-4.10) (Supplemental Table S9; Figure 2A, Model 2). Similarly, 
there was no association between use of dysphagia assessment and risk of pneumonia 
(Supplemental Figure S2A). 
[Insert Figure 1.] 
 
Death and dependency at 90-day 
There were 12% (1345/11093) of patients with missing 90-day clinical outcome data, who were 
younger and with greater pre-morbid disability compared to those with complete data 
(Supplemental Table S12).  There was no association between use of dysphagia screen itself 
and poor clinical outcome (death or disability) (aOR 0.96, 95%CI 0.81-1.13; Figure 1B).  
However, there was a significant association between those who failed compared to those who 
passed a dysphagia screen (68.1% vs. 30.8%, P<0.0001; aOR 1.66, 95%CI 1.41-2.95; 
Supplemental Table S and Figure 2B).  Compared to patients who did not have a dysphagia 
assessment, those who did had a higher risk of poor outcome (47.5% vs. 34.6%, P<0.0001; 
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Supplemental Table S9) and there was a significant association between dysphagia assessment 
and poor outcome in patients who passed a dysphagia screen (aOR 1.39, 95%CI 1.14-1.69; 
Supplemental Figure S2B). The significance of this association varied by region (Supplemental 
Figure S3).  Failing a dysphagia assessment was significantly associated with increased risks 
of pneumonia (aOR 3.04, 95% CI 2.11-4.39) and poor outcome (aOR 2.22, 95% CI 1.76-2.80; 
Supplemental Figure S4). 
[Insert Figure 2.] 
 
Subgroup analysis 
There was consistency in the relation between the use of dysphagia screening and pneumonia 
and poor outcome across patient subgroups (Supplemental Figures S5 and S6).  Although there 
was no influence of head positioning on pneumonia, there was a lower risk of poor outcome in 
patients who were allocated to the lying-flat position (aOR 0.88, 95%CI 0.77-1.00; 
Supplemental Figure S7).  Similarly, there was no heterogeneity across subgroups in the results 
according to either a pass or fail on a dysphagia screen on pneumonia and poor outcome 
(Supplemental Figures S8 and S9).  The effect of failing dysphagia screen is also consistent in 
patients with different head positions of the patients (Supplemental Figure S10B). 
Influence of feeding restrictions  
Patients who failed dysphagia screen were more likely to be placed on feeding restrictions 
compared to those passed (84.1% vs. 11.2%, p<0.0001; Table 2). The incidence of pneumonia 
and poor outcome were more in patients had feeding restrictions compared to those did not (9.5% 
vs. 0.9%, p<0.0001 and 67.6% vs. 28.7%, p<0.0001, respectively; Supplemental Table S9).  In 
the stratified analysis, subsequent use of feeding restrictions were related to higher risk of 
pneumonia, especially for patients failed a dysphagia screen or dysphagia assessment (11.9% 
vs. 1.8%, p<0.0001; Supplemental Table S12 and aOR 4.06, 95% CI 1.72-9.54; Figure S11A). 
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There was considerable regional variation in the feeding regimes provided to patients who 
failed a dysphagia screen, although use of a nasogastric tube was the most common method 
(Supplemental Table S13). 
Sensitivity analysis 
With adjustment of both baseline and hospital characteristics, and use of multiple imputation 
for missing outcome, the results were similar to our primary analyses (Supplemental Figure 
S12-S13). 
Discussion 
In this large multinational study, we found no clear association between the use of a simple 
screen or detailed assessment of dysphagia regardless of the test results, as a quality of care 
measure, and either pneumonia or poor functional outcome after acute stroke.  However, 
patients who failed either of these tests were clearly at increased risks of these adverse outcomes.  
The risk of pneumonia varied widely across regions and was related to the timing of dysphagia 
screen and assessment. 
The overall 3% frequency of pneumonia in our study was lower than reported in many other 
studies,15,17,18 but similar to that of a large registry study.19 The patients in our study were likely 
subjected to rigorous assessment and management of dysphagia by virtue of their participation 
in a clinical trial, where pneumonia was an expected adverse outcome.  However, it is likely 
that selection bias and variable definitions influence the detection and reporting of pneumonia 
across studies.  As in a real-life registry-based study, our protocol included consecutive patients 
with acute stroke.  However, we did not specify any particular procedures for investigators to 
follow, and the assessment and management of dysphagia was performed according to local 
protocols. 
14 
 
Dysphagia screening, assessment and management varies across countries in the context of 
specifications and interpretation of guidelines for stroke management.9-12  In our study, the 
median times from admission to screening and assessing dysphagia in Australia and UK were 
similar to another study conducted during 2013-2014.15  In China, dysphagia screens and 
assessments were performed at approximately the same time, although guidelines in this 
country make no specific recommendation regarding when or how to conduct them.10  Another 
UK stroke registry study has shown an association between delayed screen and assessment of 
dysphagia and increased risk of pneumonia.15  In our study, dysphagia screening was most 
delayed in South America, which may in part explain the higher rate of pneumonia (6.5%) there 
compared to other regions.  
We found no evidence of an association between the use of dysphagia screening and the risk of 
adverse outcomes.  Another cluster clinical trial also showed no association of dysphagia 
screening and risk of pneumonia but rather a relation with lower risk of death and severe 
disability,13 which may have been due to an effect of other components of the care bundle 
targeting fever and hyperglycaemia.  However, our study shows that patients who fail a 
dysphagia screen are at increased risk of pneumonia and poor clinical outcome, which is 
consistent with other studies.13,14, 21-22  The majority (84%) of patients who failed dysphagia 
screening were placed on feeding restrictions. These data are consistent with guideline 
recommendation for routine use of dysphagia screening in patients with acute stroke, with 
subsequent use of feeding restrictions or early dysphagia treatment in those who fail.   
Another finding from our study was the increased risk of pneumonia or poor clinical outcome 
in ‘screen-fail’ or ‘assessment-fail’ patients and particularly those placed on restricted feeding. 
We assume it might be related to the mixed methods of feeding practices we measured, some 
of which might introduce adverse effect. A previous retrospective study has shown that the 
presence of nasogastric feeding was associated with reduced functional recovery and increased 
15 
 
mortality after stroke.23  However, there is randomised evidence of early use of nasogastric 
tubes in dysphagia patients and lower risk of adverse outcomes,23 while dysphagia therapy 
programs appear to reduce the risk of pneumonia in the acute phase of stroke.8 We were unable 
to assess for any association of individual feeding actions on outcomes, as patients were often 
on multiple feeding restriction regimes. It is likely that analyses are complicated by indication 
bias, where high risk patients receive the intervention of interest, as our stratified analyses 
showed that patients who passed a dysphagia screen but subsequently had a dysphagia 
assessment, had higher risks of poor clinical outcome compared to other patients. Further 
studies concentrate on evaluating different methods of feeding actions subsequently after failing 
dysphagia screen, will be essential to improve patient’s clinical outcomes. 
In our study, it is interesting to note that a quarter of patients passed a dysphagia screen yet 
went on to also receive a dysphagia assessment and majority (96%) of them were reconfirmed 
as passed.  Some of them may have deteriorated after screen and therefore, required further 
assessment; however, many may not have. This duplicated assessing for dysphagia was also 
noted in the QASC trial, with similar proportion (97%) also deemed safe to swallow by the 
speech pathologist.13  Further examination of the reason for double swallowing surveillance in 
stroke patients is warranted. From another perspective, such inefficient duplicated assessment 
is costly and time-consuming, especially for some low-resourced settings. We recommend 
patients who had passed a screen and with no further deterioration should not be reviewed by a 
health professional. 
We acknowledge several limitations, including the inability to pre-specify (or standardise) the 
methods of screening and assessment used across participating centres.  As such, we were 
unable to provide any details regarding the type and quality of screening and assessments 
approaches undertaken for dysphagia, and for other aspects of background management. 
Another factor is that participants in our study are likely to have received a greater attention to 
16 
 
standard of care processes including dysphagia monitoring and feeding actions because of the 
specific nature of our clinical trial assessing the influence of head positioning on stroke 
outcomes. However, this was a pre-specified secondary analysis of a large international trial 
based on local protocol by regions. Our findings reflect usual practice according to current 
guideline recommendations across countries. A major strength of our study is the large sample 
size of patients with a broad range of characteristics from a range of healthcare settings with 
variable resourcing levels.  Moreover, selection bias was likely reduced compared to most 
conventional individual patient randomised clinical trials, by the inclusion of consecutive stroke 
patients within a cluster crossover design.  We also considered the influences of institutional 
factors in multi-level models that included adjustment for various hospital characteristics. 
Conclusions 
The utility of dysphagia screening and assessment varies according to countries and local 
guidelines. Failing a dysphagia screen was associated with higher risk of pneumonia and poor 
outcome from acute stroke. Subsequent feeding restrictions is related to increased risk of 
adverse outcomes. Further RCTs that evaluating the effects of feeding actions are urgent to 
improve patient’s outcome.  
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